Colistin susceptibility of gram-negative clinical isolates from Tamil Nadu, India

1Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48:1-12. BoucherHWTalbotGHBradleyJSEdwardsJEGilbertDRiceLBet alBad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaClin Infect Dis2009 4811210.1086/595011Search in Google Scholar

2Shorr AF. Review of studies of the impact on Gramnegative bacterial resistance on outcomes in the intensive care unit. Crit Care Med. 2009; 37:1463-9. ShorrAFReview of studies of the impact on Gramnegative bacterial resistance on outcomes in the intensive care unitCrit Care Med2009 371463910.1097/CCM.0b013e31819ced02Search in Google Scholar

3Dalfino L, Puntillo F, Mosca A, Monna R, Spada ML, Coppolecchia S, et al. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study. Clin Infect Dis. 2012; 54:1720. DalfinoLPuntilloFMoscaAMonnaRSpadaMLCoppolecchiaSet alHigh-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary studyClin Infect Dis2012 54172010.1093/cid/cis286Search in Google Scholar

4Molton JS, Tambyah PA, Brenda S, Ang P, Moi LL, Dale AF. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin Infect Dis. 2013; 56:1310-8. MoltonJSTambyahPABrendaSAngPMoiLLDaleAFThe global spread of healthcare-associated multidrug-resistant bacteria: a perspective from AsiaClin Infect Dis2013 561310810.1093/cid/cit020Search in Google Scholar

5Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner C, et al. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis. 2006; 6:589-601. LiJNationRLTurnidgeJDMilneRWCoulthardKRaynerCet alColistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infectionsLancet Infect Dis2006 658960110.1016/S1473-3099(06)70580-1Search in Google Scholar

6Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis. 2005; 40:1333. FalagasMEKasiakouSKColistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infectionsClin Infect Dis2005 40133310.1086/429323Search in Google Scholar

7Kumazawa J, Yagisawa M. The history of antibiotics: the Japanese story. J Infect Chemother. 2002; 8:125. KumazawaJYagisawaMThe history of antibiotics: the Japanese storyJ Infect Chemother2002 812510.1007/s101560200022Search in Google Scholar

8Levin AS, Barone AA, Penco J, Santos MV, Arruda EA, Manrique EI, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis. 1999; 28: 1008. LevinASBaroneAAPencoJSantosMVArrudaEAManriqueEIet alIntravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClin Infect Dis1999 28100810.1086/514732Search in Google Scholar

9Garnacho-Montero J, Ortiz-Leyba C, Jim nez-Jim nez FJ, Barrero-Almod var AE, Garc a-Garmendia JL, Bernaneu-Wittell M, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis. 2003; 36:1111. Garnacho-MonteroJOrtiz-LeybaCJim nez-Jim nezFJBarrero-Almodvar AEGarca-Garmendia JLBernaneu-WittellMet alTreatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAPClin Infect Dis2003 36111110.1086/374337Search in Google Scholar

10Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos L, et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care. 2003; 7:R78. MarkouNApostolakosHKoumoudiouCAthanasiouMKoutsoukouAAlamanosLet alIntravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patientsCrit Care2003 7R7810.1186/cc2358Search in Google Scholar

11Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis. 2003; 37: e154. LindenPKKusneSColeyKFontesPKramerDJPatersonDUse of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosaClin Infect Dis2003 37e15410.1086/379611Search in Google Scholar

12Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multi-resistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect. 2005; 11: 115. MichalopoulosASTsiodrasSRellosKMentzelopoulosSFalagasMEColistin treatment in patients with ICU-acquired infections caused by multi-resistant Gram-negative bacteria: the renaissance of an old antibioticClin Microbiol Infect2005 1111510.1111/j.1469-0691.2004.01043.xSearch in Google Scholar

13Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother. 1999; 33: 960. EvansMEFeolaDJRappRPPolymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteriaAnn Pharmacother1999 3396010.1345/aph.18426Search in Google Scholar

14Li J, Turnidge J, Milne R, Nation RL, Coulthard K. In vitro pharmacodynamic properties of colistin and colistinmethanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother. 2001; 45:781. LiJTurnidgeJMilneRNationRLCoulthardKIn vitro pharmacodynamic properties of colistin and colistinmethanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosisAntimicrob Agents Chemother2001 4578110.1128/AAC.45.3.781-785.2001Search in Google Scholar

15Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, D’Amato G et al. Antiendotoxin activity of antimicrobial peptides and glycopeptides. J Chemother. 2003; 15:129. GiacomettiACirioniOGhiselliROrlandoFMocchegianiFD’AmatoGet alAntiendotoxin activity of antimicrobial peptides and glycopeptidesJ Chemother2003 1512910.1179/joc.2003.15.2.129Search in Google Scholar

16Warren HS, Kania SA, Siber GR. Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide. Antimicrob Agents Chemother. 1985; 28:107. WarrenHSKaniaSASiberGRBinding and neutralization of bacterial lipopolysaccharide by colistin nonapeptideAntimicrob Agents Chemother1985 2810710.1128/AAC.28.1.107Search in Google Scholar

17Pitt TL, Sparrow M, Warner M, Stefanidou M. Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax. 2003; 58: 794. PittTLSparrowMWarnerMStefanidouMSurvey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agentsThorax2003 5879410.1136/thorax.58.9.794Search in Google Scholar

18Vicari G, Bauer SR, Neuner EA, Lam SW. Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant Gram-negative bacteremia. Clin Infect Dis. 2013; 56:398. VicariGBauerNeunerEALamSWAssociation between colistin dose and microbiologic outcomes in patients with multidrug-resistant Gram-negative bacteremiaClin Infect Dis2013 5639810.1093/cid/cis909Search in Google Scholar

19Pena I, Picazoa JJ, Rodriguez-Avial C, Rodriguez-Avial I. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates. Int J Antimicrob Agents. 2014; 43:460-4. PenaIPicazoaJJRodriguez-AvialCRodriguez-AvialICarbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolatesInt J Antimicrob Agents2014 43460410.1016/j.ijantimicag.2014.01.021Search in Google Scholar

20Capone A, Giannella M, Fortini D, Giordano A, Meledandri M, Ballardini M, et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect. 2013; 19E23-30. CaponeAGiannellaMFortiniDGiordanoAMeledandriMBallardiniMet alHigh rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortalityClin Microbiol Infect2013 19E233010.1111/1469-0691.12070Search in Google Scholar

21Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother. 2012; 67:1607-15. CaiYChaiDWangRLiangBBaiNColistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategiesJ Antimicrob Chemother2012 6716071510.1093/jac/dks084Search in Google Scholar

22Chen S, Hu F, Zhang X, Xu X, Liu L, Zhu D, et al. Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatment. J Clin Microbiol. 2011; 49:4022-3. ChenSHuFZhangXXuXLiuLZhuDet alIndependent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatmentJ Clin Microbiol2011 494022310.1128/JCM.01233-11Search in Google Scholar

23Urban C, Tiruvury H, Mariano N, Colon-Urban R, Rahal JJ. Polymyxin-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother. 2011; 55:388-9. UrbanCTiruvuryHMarianoNColon-UrbanRRahalJJPolymyxin-resistant clinical isolates of Escherichia coliAntimicrob Agents Chemother2011 55388910.1128/AAC.01088-10Search in Google Scholar

24Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, et al. Hetero-resistance to colistin in multi-drug resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2006; 50:2946-50. LiJRaynerCRNationRLOwenRJSpelmanDTanKEet alHetero-resistance to colistin in multi-drug resistant Acinetobacter baumanniiAntimicrob Agents Chemother2006 5029465010.1128/AAC.00103-06Search in Google Scholar

25Arroyo LA, Garcia-Curiel A, Pachón-Ibañez ME, Llanos AC, Ruiz M, Pachón J, et al. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005; 43:903-5. ArroyoLAGarcia-CurielAPachón-IbañezMELlanosACRuizMPachónJet alReliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumanniiJ Clin Microbiol2005 43903510.1128/JCM.43.2.903-905.2005Search in Google Scholar

26Ko KS, Suh JY, Kwon KT, Jung Si, Park KH, Chung DR, et al. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother. 2007; 60:1163-7. KoKSSuhJYKwonKTJungSiParkKHChungDRet alHigh rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from KoreaJ Antimicrob Chemother2007 601163710.1093/jac/dkm305Search in Google Scholar

27Antoniadou A, Kontopidou F, Poulakou G Koratzanis E, Galani I, Papadomichelakis E, et al. Colistin resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother. 2007; 59: 786-90. AntoniadouAKontopidouFPoulakouG Koratzanis EGalaniIPapadomichelakisEet alColistin resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal clusterJ Antimicrob Chemother2007 597869010.1093/jac/dkl562Search in Google Scholar

28Poudyal A, Howden B, Bell J, Gao W, Owen RJ, Turnidge JD, et al. In vitro pharmacodynamics of colistin against multi-drug resistant Klebsiella pneumoniae. J Antimicrob Chemother. 2008; 62: 1311-8. PoudyalAHowdenBBellJGaoWOwenRJTurnidgeJDet alIn vitro pharmacodynamics of colistin against multi-drug resistant Klebsiella pneumoniaeJ Antimicrob Chemother2008 621311810.1093/jac/dkn425Search in Google Scholar

29Suh J-Y, Son JS, Chung DR, Peck KR, Ko KS, Song J-H. Nonclonal emergence of colistin resistant Klebsiella pneumoniae isolates from blood samples in South Korea. Antimicrob Agents Chemother. 2010; 54:560-2. SuhJ-YSonJSChungDRPeckKRKoKSSongJ-HNonclonal emergence of colistin resistant Klebsiella pneumoniae isolates from blood samples in South KoreaAntimicrob Agents Chemother2010 54560210.1128/AAC.00762-09Search in Google Scholar